Expression of human apolipoprotein A-II apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia

Journal of Lipid Research

Volumn 41, Issue 8, 2000, Pages 1328-1338

  Escolà Gil, Joan Carles ^a   Julve, Josep ^a   Marzal Casacuberta, Àfrica ^a   Ordóñez Llanos, Jordi ^a,b   González Sastre, Francesc ^a,b   Blanco Vaca, Francisco ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

ApoB; Atherosclerosis; High density lipoprotein; Transgenic mice; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN E; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; LIPOPROTEIN SYNTHESIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN A-II; APOLIPOPROTEINS B; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; INSULIN; LIPASE; LIPOLYSIS; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MICE; MICE, TRANSGENIC; TRIGLYCERIDES;

EID: 0033846955     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Mouse models of atherosclerosis
2. Disruption of the murine lecithin: Cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I
3. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
4. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
5. A splice-junction mutation responsible for familial apoA-II deficiency
6. Contrasting in vivo effects of murine and human apolipoprotein A-II
7. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensivity in apoA-II knock-out mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility
8. Functional lecithin: Cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
9. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: Evidence of a potentially relevant species-specific interaction with diet
10. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
11. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
12. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans
13. Interstitial fluid apolipoprotein A-II: An association with the occurrence of myocardial infarction
14. Linkage of familial combined hyperlipidaemia to chromosome 1q 21-q23
15. Linkage of a candidate gene locus to familial combined hyperlipidemia. Lecithin: Cholesterol acyltransferase on 16q
16. Generation of mice carrying a mutant apolipoprotein E. gene inactivated by gene targeting in embryonic stem cells
17. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding
18. Lipoprotein lipase and hepatic lipase activities are differentially regulated in isolated hepatocytes from neonatal rats
19. Overexpression of apolipoprotein A-II in transgenic mice converts high density lipoproteins to proinflammatory particles
20. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions
21. Lipid extraction of tissues with a low-toxicity solvent
22. Mildly oxidized LDL induces an increased apolipoproteinJ/paraoxonase ratio
23. Novel genes for familial combined hyperlipidemia
24. Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: Cholesterol acyltransferase deficiency
25. Molecular basis of fish-eye disease in a patient from Spain
26. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
27. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
28. Targeted disruption of the mouse lecithin: Cholesterol acyltransferase (LCAT) gene
29. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia
30. Divergent responses of the liver to increased delivery of glucose or fatty acids: Implications for the pathogenesis of type IV hyperlipoproteinemia
31. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to a defective very low density lipoprotein hydrolysis
32. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
33. Mapping a gene for combined hyperlipidemia in a mutant mouse strain
34. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B background, and restoration of apolipoprotein mRNA-editing by somatic gene transfer of apobec-1
35. 1 mice
36. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL
37. Relationships between the metabolism of high density and very-low density lipoproteins in man: Studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity
38. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice
39. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice
40. The Msp I polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity
41. Association between apolipoprotein A2 MspI polymorphism and hypertriglyceridemia in Koreans
42. Variability of plasma apolipoprotein (apo) A-II levels associated with an apoA-II gene polymorphism in monozygotic twin pairs
43. How much of variability in apolipoprotein A-II concentration is explained by polymorphism adjacent to apoA-II gene?
44. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial
45. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II
46. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice